Keybanc Maintains Overweight on Denbury, Raises Price Target to $95
Keybanc maintains Denbury (NYSE:DEN) with a Overweight and raises the price target from $87 to $95.
Keybanc Maintains Overweight on Denbury, Raises Price Target to $87
Keybanc analyst Leo Mariani maintains Denbury (NYSE:DEN) with a Overweight and raises the price target from $86 to $87.
What 5 Analyst Ratings Have To Say About Denbury
Denbury (NYSE:DEN) has observed the following analyst ratings within the last quarter:
MKM Partners Initiates Coverage On Denbury with Buy Rating, Announces Price Target of $96
MKM Partners analyst John Gerdes initiates coverage on Denbury (NYSE:DEN) with a Buy rating and announces Price Target of $96.
Denbury Q2 EPS $0.61 Beats $0.53 Estimate, Sales $301.37M Beat $253.04M Estimate
Denbury (NYSE:DEN) reported quarterly earnings of $0.61 per share which beat the analyst consensus estimate of $0.53 by 15.09 percent. This is a 971.43 percent increase over losses of $(0.07) per share from the same
Earnings Scheduled For August 5, 2021
Companies Reporting Before The Bell
• OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million.
Roth Capital Downgrades Denbury to Neutral, Raises Price Target to $78.75
Roth Capital analyst John White downgrades Denbury (NYSE:DEN) from Buy to Neutral and raises the price target from $57 to $78.75.
Stocks That Hit 52-Week Highs On Thursday
Before 10 a.m. ET on Thursday, 145 companies set new 52-week highs.